Press Releases

Featured Press Releases

BIO Statement on Passage of the Reconciliation…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on passage of the One, Big, Beautiful Bill Act (OBBBA):“The OBBBA contains important bipartisan provisions…

Learn more

Massachusetts Governor Maura Healey Named BIO’s…

Annual award honors governors for their leadership and commitment to strengthening biotechnology in their state BOSTON (June 17, 2025) – Today, the Biotechnology Innovation Organization (BIO) named Massachusetts Governor Maura Healey…

Learn more

BIO Elects Genentech’s Fritz Bittenbender as New…

Industry veteran takes the helm as Dr. Ted Love concludes two-year term marked by strategic growth and transition BOSTON (June 16, 2025) – Today, the Biotechnology Innovation Organization (BIO) announced that Fritz Bittenbender,…

Learn more

BIO Statement on National Academies’ Consensus Study on Human Gene Editing

February 14, 2017

Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement regarding the Consensus Study on Human Gene Editing, released today by the Human Gene Editing Initiative of the National Academies…

EU’s Anti-Science Comitology Reform Threatens Innovation

February 14, 2017

Washington, D.C. (February 14, 2017) – The European Commission announced today a proposal to revise its Comitology Regulation forcing policy decisions to individual EU member countries.

BIO Announces Gary Andres as the New Senior Executive Vice President of Public Affairs

February 14, 2017

Long-time Majority Staff Director of the House Energy and Commerce Committee Dr. Gary Andres joins BIO as Senior Executive Vice President of Public Affairs.

Registration Now Open for the 14th Annual BIO World Congress on Industrial Biotechnology

February 8, 2017

BIO announced registration and housing are now open for the 2017 World Congress on Industrial Biotechnology. The conference will be held July 23-26, 2017 at the Palais des congrès de Montréal in Montréal,…

BIO Statement on President Trump’s Comments Supporting Biopharmaceutical Competition and Innovation

January 31, 2017

Washington, DC (January 31, 2017) – BIO issued the following statement regarding President Trump’s comments today supporting biopharmaceutical innovation:

BIO Statement on USDA and FDA Actions related to Pre-market Regulatory Oversight of Plant and Animal Organisms

January 18, 2017

The U.S. Department of Agriculture (USDA) and the U.S. Food and Drug Administration (FDA) published today four documents related to the pre-market regulatory oversight of a variety of biology-based agricultural tools, including genetically…

BIO’s Jim Greenwood Meets with India’s PM Modi

January 13, 2017

Delivers Message: India Must Protects Innovators’ Work Product

BIO Statement on Proposed Maryland Drug Pricing Legislation

January 10, 2017

BIO's statement regarding proposed drug pricing legislation within the Maryland Senate.

BIO CEO & Investor Conference Programming Announced

December 15, 2016

BIO announced programming for the 19th annual BIO CEO & Investor Conference. Held February 13-14 at the Waldorf Astoria in New York, the annual conference provides an environment for investors, analysts, industry executives and others to…

BIO Applauds Senate Passage of the 21st Century Cures Act

December 7, 2016

Washington, DC (December 7, 2016) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the 21st Century Cures Act by the U.S. Senate:

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.